Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rotondi

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Current Pharmaceutical Design|August 26, 2011
The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptorMario Rotondi, Luca Chiovato
The Journal of Clinical Endocrinology and Metabolism|December 20, 2021
Preexisting or Concomitant Thyroiditis in Papillary Thyroid Cancer: Something More Than a Mere Issue of Timing?Mario Rotondi, Luca Chiovato
Endocrine|August 29, 2012
Vitamin D deficiency in patients with Graves' disease: probably something more than a casual associationMario Rotondi, Luca Chiovato
JAMA|December 9, 2010
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidismMario Rotondi, Flavia Magri, Luca Chiovato
The New England Journal of Medicine|September 30, 2008
Graves' diseaseMario Rotondi, Rodolfo Fonte, Luca Chiovato
Clinical Endocrinology|May 3, 2006
Maternal hypothyroidism in early gestation: possible preventive strategiesMario Rotondi, Sara Precerutti, Luca Chiovato
Frontiers in Immunology|May 13, 2021
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!Francesca Coperchini, Luca Chiovato, Mario Rotondi
Cytokine & Growth Factor Reviews|September 10, 2013
CXCL8 in thyroid disease: from basic notions to potential applications in clinical practiceMario Rotondi, Francesca Coperchini, Luca Chiovato
The Journal of Clinical Endocrinology and Metabolism|February 8, 2011
Thyroid and obesity: not a one-way interactionMario Rotondi, Flavia Magri, Luca Chiovato
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2014
Disease modifying therapies in multiple sclerosis: could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?Mario Rotondi, Roberto Bergamaschi, Luca Chiovato
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Current Pharmaceutical Design|August 26, 2011
The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptorMario Rotondi, Luca Chiovato
The Journal of Clinical Endocrinology and Metabolism|December 20, 2021
Preexisting or Concomitant Thyroiditis in Papillary Thyroid Cancer: Something More Than a Mere Issue of Timing?Mario Rotondi, Luca Chiovato
Endocrine|August 29, 2012
Vitamin D deficiency in patients with Graves' disease: probably something more than a casual associationMario Rotondi, Luca Chiovato
JAMA|December 9, 2010
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidismMario Rotondi, Flavia Magri, Luca Chiovato
The New England Journal of Medicine|September 30, 2008
Graves' diseaseMario Rotondi, Rodolfo Fonte, Luca Chiovato
Clinical Endocrinology|May 3, 2006
Maternal hypothyroidism in early gestation: possible preventive strategiesMario Rotondi, Sara Precerutti, Luca Chiovato
Frontiers in Immunology|May 13, 2021
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!Francesca Coperchini, Luca Chiovato, Mario Rotondi
Cytokine & Growth Factor Reviews|September 10, 2013
CXCL8 in thyroid disease: from basic notions to potential applications in clinical practiceMario Rotondi, Francesca Coperchini, Luca Chiovato
The Journal of Clinical Endocrinology and Metabolism|February 8, 2011
Thyroid and obesity: not a one-way interactionMario Rotondi, Flavia Magri, Luca Chiovato
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2014
Disease modifying therapies in multiple sclerosis: could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?Mario Rotondi, Roberto Bergamaschi, Luca Chiovato
Pageof 21